Editorial Board
Editor-in-Chief
-
Professor, Laboratory Medical Oncology, VU University Medical Center, Amsterdam, Netherlands
Editorial Board Members
-
Professor, Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel -
President of the Oncoclinical Institute and Director of the Oncoclinica Group, Rio de Janeiro, Brazil -
Professor, Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium -
Associate Professor, Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy. -
Professor, Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA -
Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil -
Professor, Clinical Pharmacy Group, Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany -
Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands -
Division of Medical Oncology, University of Basel, Basel, Switzerland -
Institute of Pharmacy, University of Bonn, Bonn, Germany -
 Kwok.png)
Professor, Faculty of Health Sciences, University of Macau, Macau, China -
Professor, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA -
Professor, School of Biosciences, University of Kent, Canterbury, UK. -
Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA -
Department of Health Sciences, University of Florence, Florence, Italy -
Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland -
Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy -
Professor, School of Pharmacy, University of Huddersfield, Huddersfield, UK -
Professor, Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain -
Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal -
Professor, Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, USA -
Professor, Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany -
Executive Medical Director, Global Oncology and Hematology, Syneos Health. President, Ares Pharmaceuticals, White Bear Lake, MN, USA -
Professor, Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan -
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA -
Professor, Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan -
Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy